111 Capital Acquires New Holdings in Stryker Corporation $SYK

111 Capital bought a new position in shares of Stryker Corporation (NYSE:SYK) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 3,763 shares of the medical technology company’s stock, valued at approximately $1,391,000.

Other large investors have also recently bought and sold shares of the company. Clayton Financial Group LLC bought a new position in shares of Stryker in the third quarter worth $26,000. Elevation Point Wealth Partners LLC purchased a new position in Stryker during the second quarter worth about $28,000. Kilter Group LLC bought a new position in Stryker in the 2nd quarter worth about $29,000. Howard Hughes Medical Institute purchased a new stake in shares of Stryker in the 2nd quarter valued at about $29,000. Finally, ANTIPODES PARTNERS Ltd purchased a new stake in shares of Stryker in the 3rd quarter valued at about $34,000. 77.09% of the stock is owned by institutional investors.

Insider Activity

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of the business’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total value of $90,730,000.00. Following the transaction, the director owned 2,457,331 shares in the company, valued at approximately $891,814,566.52. The trade was a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 5.20% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently weighed in on SYK. Robert W. Baird set a $437.00 price objective on shares of Stryker in a research report on Friday, January 30th. Citizens Jmp raised shares of Stryker from a “market perform” rating to an “outperform” rating and set a $440.00 price target for the company in a research note on Friday, December 19th. Sanford C. Bernstein raised their price objective on shares of Stryker from $450.00 to $465.00 and gave the company an “outperform” rating in a research report on Friday, January 9th. Wall Street Zen raised shares of Stryker from a “hold” rating to a “buy” rating in a report on Saturday, February 21st. Finally, Barclays reissued an “overweight” rating and issued a $469.00 target price on shares of Stryker in a research note on Monday, February 2nd. Thirteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $426.47.

Stryker Price Performance

SYK opened at $387.34 on Monday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.89 and a quick ratio of 1.21. The stock’s 50 day simple moving average is $363.17 and its 200 day simple moving average is $369.09. The firm has a market cap of $148.23 billion, a price-to-earnings ratio of 46.11, a PEG ratio of 2.26 and a beta of 0.85. Stryker Corporation has a 1 year low of $329.16 and a 1 year high of $404.87.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 earnings per share for the quarter, beating analysts’ consensus estimates of $4.40 by $0.07. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The firm had revenue of $7.17 billion during the quarter, compared to analyst estimates of $7.12 billion. During the same quarter in the prior year, the firm posted $4.01 earnings per share. The business’s quarterly revenue was up 11.4% compared to the same quarter last year. As a group, analysts predict that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, March 31st. Stryker’s dividend payout ratio (DPR) is 41.90%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.